Sağlık·13.06.2026AI özeti Chinese researchers' findings influencing global urological cancer treatment, says expert
Chinese urological cancer experts are now influencing global treatment models, according to Professor Ye Dingwei. At the 2026 ASCO annual meeting, five studies from China were presented, with Ye's team from Fudan University Shanghai Cancer Center contributing three oral presentations on bladder and prostate cancer. Their research focuses on optimizing perioperative strategies, first-line treatments for advanced cancers, and salvage therapies for drug-resistant cases, marking a shift from surgical platforms to comprehensive treatment and original research.